Ferric bepectate clinical trials
Also written Feramyl.
How each study uses ferric bepectate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the ferric bepectate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2018 (1)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 2
Prof. Dr. Frank Behrens (1) · AFT Pharmaceuticals, Ltd. (1) · Dr. Frank Behrens (1)
Studies
Open first, then newest update. How each study uses ferric bepectate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency AnemiaNot yet recruitingPhase 3AFT Pharmaceuticals, Ltd.NCT07687784Written as Ferric Bepectate IV Injection
- Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron DeficiencyCompletedPhase 3Prof. Dr. Frank BehrensNCT03817957Written as Polyglucoferron
- Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in PatientsWithdrawnPhase 3Dr. Frank BehrensNCT04087993Written as Polyglucoferron
Codes
What other systems call ferric bepectate · ClinicalTrials.gg INT016466
- UNII (FDA) EIR821H5M6FERRIC BEPECTATEOne source FDA
- NCI Thesaurus C177081Ferric BepectateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | EIR821H5M6 | FERRIC BEPECTATE | One source FDA |
| NCI Thesaurus | C177081 | Ferric Bepectate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.